[go: up one dir, main page]

FI970918L - Yhdisteet ja menetelmät syövän hoitamiseksi - Google Patents

Yhdisteet ja menetelmät syövän hoitamiseksi Download PDF

Info

Publication number
FI970918L
FI970918L FI970918A FI970918A FI970918L FI 970918 L FI970918 L FI 970918L FI 970918 A FI970918 A FI 970918A FI 970918 A FI970918 A FI 970918A FI 970918 L FI970918 L FI 970918L
Authority
FI
Finland
Prior art keywords
compounds
methods
treating cancer
cancer
treating
Prior art date
Application number
FI970918A
Other languages
English (en)
Swedish (sv)
Other versions
FI970918A0 (fi
FI970918A7 (fi
Inventor
Chung K Chu
Yung-Chi Cheng
Original Assignee
Univ Georgia
Univ Yale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/301,298 external-priority patent/US5817667A/en
Application filed by Univ Georgia, Univ Yale filed Critical Univ Georgia
Publication of FI970918A0 publication Critical patent/FI970918A0/fi
Publication of FI970918A7 publication Critical patent/FI970918A7/fi
Publication of FI970918L publication Critical patent/FI970918L/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
FI970918A 1994-09-06 1995-09-05 Yhdisteet ja menetelmät syövän hoitamiseksi FI970918L (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/301,298 US5817667A (en) 1991-04-17 1994-09-06 Compounds and methods for the treatment of cancer
US39063395A 1995-02-17 1995-02-17
PCT/US1995/011464 WO1996007413A1 (en) 1994-09-06 1995-09-05 Compounds and methods for the treatment of cancer

Publications (3)

Publication Number Publication Date
FI970918A0 FI970918A0 (fi) 1997-03-04
FI970918A7 FI970918A7 (fi) 1997-05-02
FI970918L true FI970918L (fi) 1997-05-02

Family

ID=26972285

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970918A FI970918L (fi) 1994-09-06 1995-09-05 Yhdisteet ja menetelmät syövän hoitamiseksi

Country Status (31)

Country Link
US (3) US6063787A (fi)
EP (2) EP0781136B1 (fi)
JP (1) JP3979662B2 (fi)
KR (1) KR100374477B1 (fi)
CN (3) CN1827108A (fi)
AP (1) AP783A (fi)
AT (1) ATE267015T1 (fi)
AU (1) AU704977B2 (fi)
BG (1) BG63122B1 (fi)
BR (1) BR9508886A (fi)
CA (1) CA2199117C (fi)
CZ (1) CZ297873B6 (fi)
DE (1) DE69533066T2 (fi)
DK (1) DK0781136T3 (fi)
ES (1) ES2219666T3 (fi)
FI (1) FI970918L (fi)
HU (1) HUT77172A (fi)
IL (1) IL115156A (fi)
IS (1) IS2011B (fi)
MY (1) MY121548A (fi)
NO (1) NO313268B1 (fi)
NZ (1) NZ335013A (fi)
OA (1) OA10473A (fi)
PL (2) PL189288B1 (fi)
PT (1) PT781136E (fi)
RO (1) RO118748B1 (fi)
RU (1) RU2168995C2 (fi)
SI (1) SI0781136T1 (fi)
SK (1) SK284564B6 (fi)
WO (1) WO1996007413A1 (fi)
ZA (1) ZA957483B (fi)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6903224B2 (en) 1988-04-11 2005-06-07 Biochem Pharma Inc. Substituted 1,3-oxathiolanes
US5728575A (en) * 1990-02-01 1998-03-17 Emory University Method of resolution of 1,3-oxathiolane nucleoside enantiomers
IL115156A (en) * 1994-09-06 2000-07-16 Univ Georgia Pharmaceutical compositions for the treatment of cancer comprising 1-(2-hydroxymethyl-1,3-dioxolan-4-yl) cytosines
US6022876A (en) * 1996-11-15 2000-02-08 Yale University L-β-dioxolane uridine analogs and methods for treating and preventing Epstein-Barr virus infections
WO1999008110A1 (en) 1997-08-08 1999-02-18 Newbiotics, Inc. Methods and compositions for overcoming resistance to biologic and chemotherapy
JP2002500880A (ja) 1998-01-23 2002-01-15 ニューバイオティックス インコーポレイテッド 酵素に触媒される治療剤
US7462605B2 (en) 1998-01-23 2008-12-09 Celmed Oncology (Usa), Inc. Phosphoramidate compounds and methods of use
BR9908270A (pt) 1998-02-25 2004-06-29 Univ Emory 2-fluoro-nucleosìdeos, composições farmacêuticas e seus usos
AU2004201676B2 (en) * 1999-03-29 2006-03-09 University Of Georgia Research Foundation, Inc. Methods of treating leukemia
DK1165096T3 (da) * 1999-03-29 2010-01-25 Shire Canada Inc Anvendelse af cytidinderivater til behandling af leukæmi
US6653318B1 (en) 1999-07-21 2003-11-25 Yale University 5-(E)-Bromovinyl uracil analogues and related pyrimidine nucleosides as anti-viral agents and methods of use
US6683061B1 (en) 1999-07-22 2004-01-27 Newbiotics, Inc. Enzyme catalyzed therapeutic activation
WO2001022950A2 (en) 1999-09-24 2001-04-05 Shire Biochem Inc. Diosolane nucleoside analogs for the treatment or prevention of viral infection
EP1225899A2 (en) 1999-11-04 2002-07-31 Virochem Pharma Inc. Method for the treatment or prevention of flaviviridae viral infection using nucleoside analogues
EP1600451A3 (en) 1999-11-12 2008-09-10 Pharmasset, Inc. Synthesis of 2'-deoxy-l-nucleosides
JP2004510832A (ja) * 2000-10-13 2004-04-08 シャイアー・バイオケム・インコーポレイテッド 改善された細胞間送達のためのジオキソランアナログ
EP1359921A4 (en) 2001-01-19 2006-09-06 Newbiotics Inc METHODS RELATING TO THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES
CN1744902B (zh) * 2001-03-23 2010-05-26 希拉加拿大股份有限公司 治疗癌症的药物组合
CA2441568A1 (en) 2001-03-23 2002-10-03 Shire Biochem Inc. Pharmaceutical combinations for the treatment of cancer
AU2002242561A1 (en) * 2001-03-30 2002-10-15 Shire Biochem Inc. Methods of treating cancer using cyplastin combined with a dioxolane nucleoside such as troxacitabine
AU2002336864B2 (en) * 2001-11-02 2006-08-17 Shire Biochem Inc. Pharmaceutical compositions for the treatment of leukemia comprising dioxolane nucleosides analogs
IL161625A0 (en) * 2001-11-19 2004-09-27 Medigene Ag Medicament for the treatment of viral skin and tumour diseases
MXPA04002365A (es) 2002-06-21 2004-11-22 Lg Electronics Inc Medio de grabacion que tiene estructura de datos para manejar la reproduccion de datos de video grabados en el mismo.
CN1556988B (zh) 2002-06-21 2011-09-14 Lg电子株式会社 具有用于管理记录在其上面的视频数据的再现的数据结构的记录介质
KR20040000290A (ko) 2002-06-24 2004-01-03 엘지전자 주식회사 고밀도 광디스크의 멀티 경로 데이터 스트림 관리방법
BR0305211A (pt) 2002-06-24 2005-06-28 Lg Electronics Inc Meio de gravação possuindo estrutura de dados para gerenciamento de reprodução de dados de vìdeo de trajetória de reprodução múltipla gravados no mesmo e aparelhos e métodos de gravação e reprodução
KR100554767B1 (ko) 2002-06-28 2006-02-22 엘지전자 주식회사 다중 경로 데이터의 기록 및 재생을 관리하기 위한 데이터구조를 갖는 기록 매체와 그에 따른 기록 및 재생 방법 및장치
WO2004028542A1 (en) * 2002-09-24 2004-04-08 Novartis Ag Use of 4-pyridylmethyl-phthalazine derivatives for the manufacture of a medicament for the treatment of myelodysplastic syndromes
JP4431043B2 (ja) 2002-10-14 2010-03-10 エルジー エレクトロニクス インコーポレイティド 記録された複数のオーディオストリームの再生を管理するためのデータ構造を有する光ディスク、それによる記録及び再生方法及び装置
KR100672111B1 (ko) 2002-10-15 2007-01-19 엘지전자 주식회사 기록된 복수의 그래픽 스트림의 재생을 관리하기 위한데이터 구조를 갖는 기록 매체, 그에 따른 기록 및 재생방법 및 장치
ES2541122T3 (es) 2002-11-12 2015-07-16 Lg Electronics Inc. Medio de grabación que tiene una estructura de datos para gestionar la reproducción de datos de vídeo de múltiples trayectorias de reproducción grabados en el mismo y métodos y aparatos de grabación y reproducción
US7720356B2 (en) 2002-11-12 2010-05-18 Lg Electronics Inc Recording medium having data structure for managing reproduction of multiple reproduction path video data recorded thereon and recording and reproducing methods and apparatuses
US7664372B2 (en) 2002-11-20 2010-02-16 Lg Electronics Inc. Recording medium having data structure for managing reproduction of multiple component data recorded thereon and recording and reproducing methods and apparatuses
US7606463B2 (en) 2003-02-24 2009-10-20 Lg Electronics, Inc. Recording medium having data structure for managing playback control and recording and reproducing methods and apparatuses
US7693394B2 (en) 2003-02-26 2010-04-06 Lg Electronics Inc. Recording medium having data structure for managing reproduction of data streams recorded thereon and recording and reproducing methods and apparatuses
US7809775B2 (en) 2003-02-27 2010-10-05 Lg Electronics, Inc. Recording medium having data structure for managing playback control recorded thereon and recording and reproducing methods and apparatuses
WO2004077417A1 (en) 2003-02-28 2004-09-10 Lg Electronics Inc. Recording medium having data structure for managing random/shuffle reproduction of video data recorded thereon and recording and reproducing methods and apparatuses
US7620301B2 (en) 2003-04-04 2009-11-17 Lg Electronics Inc. System and method for resuming playback
CA2541405C (en) 2003-10-09 2014-07-29 Medigene Ag The use of a polyphenol for the treatment of a cancerous or pre-cancerous lesion of the skin
JP5149168B2 (ja) * 2005-06-07 2013-02-20 エール ユニヴァーシティ Ｌｆｍａｕおよびｌｄｔを用いる癌および他の症状または病状の処置方法
CN101511375B (zh) * 2005-12-02 2012-09-05 耶鲁大学 L-胞嘧啶核苷类似物在制备用于治疗癌症和其它病症或疾病状态的药物中的应用
NO324263B1 (no) * 2005-12-08 2007-09-17 Clavis Pharma Asa Kjemiske forbindelser, anvendelse derav ved behandling av kreft, samt farmasoytiske preparater som omfatter slike forbindelser
AU2007293377A1 (en) * 2006-09-01 2008-03-13 University Of Georgia Research Foundation, Inc. L- OddC prodrugs for cancer
RU2322243C1 (ru) * 2006-10-20 2008-04-20 Наталья Юрьевна Костюкова Фармацевтическая композиция для лечения поражений роговицы
CN102406649A (zh) * 2011-11-15 2012-04-11 张始状 人体五种正常碱基在制备治疗肿瘤药物中的应用
CN103720693A (zh) * 2011-11-15 2014-04-16 张始状 人体五种正常碱基在制备治疗肿瘤药物中的应用
SG10201609131YA (en) 2016-11-01 2018-06-28 Xylonix Ip Holdings Pte Ltd Zinc-pga compositions and methods for treating cancer
US20190330655A1 (en) * 2016-12-28 2019-10-31 Transgene Sa Oncolytic viruses and therapeutic molecules
SG10201708886RA (en) * 2017-10-30 2019-05-30 Xylonix Ip Holdings Pte Ltd α-PGA-ZINC COMPOSITIONS AND METHODS FOR TREATING CANCER

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4000137A (en) * 1975-06-10 1976-12-28 American Home Products Corporation Antitumor derivatives of periodate-oxidized nucleosides
JPS5668674A (en) * 1979-11-08 1981-06-09 Shionogi & Co Ltd 5-fluorouracil derivative
PT82580B (pt) * 1985-05-15 1989-01-17 Wellcome Found Processo para a preparacao de 2',3'- didesoxinucleosidos e de composicoes farmaceuticas que os contem
WO1987001284A1 (en) * 1985-08-26 1987-03-12 United States Of America, Represented By The Unite Inhibition of in vitro infectivity and cytopathic effect of htlv-iii/lav by 2',3'-dideoxynosine, 2',3'-dideoxyguanosine, or 2',3'-dideoxyadenosine
US4879277A (en) * 1985-08-26 1989-11-07 The United States Of America As Represented By The Department Of Health And Human Services Antiviral compositions and methods
DE3650741T2 (de) * 1985-09-17 2000-10-12 The Wellcome Foundation Ltd., Greenford Kombination therapeutische Nukleoside mit weiteren therapeutisch wirksamen Komponenten.
IN164556B (fi) * 1986-03-06 1989-04-08 Takeda Chemical Industries Ltd
US4916122A (en) * 1987-01-28 1990-04-10 University Of Georgia Research Foundation, Inc. 3'-Azido-2',3'-dideoxyuridine anti-retroviral composition
FR2601385B1 (fr) * 1986-07-09 1989-09-29 Sucre Rech & Dev Procede de preparation a partir de saccharose d'un melange de sucres a haute teneur en isomaltose par voie enzymatique et produits obtenus
US4963533A (en) * 1986-10-24 1990-10-16 Stichting Rega Vzw (Rega) Therapeutic application of dideoxycytidinene
US5215971A (en) * 1986-12-19 1993-06-01 Medivir Ab Antiviral pharmaceutical composition comprising 5-substituted pyrimidine nucleosides
ATE108183T1 (de) * 1987-03-24 1994-07-15 Nycomed Imaging As 2',3'-dideoxyribofuranoxid-derivate.
US5185437A (en) * 1987-04-09 1993-02-09 Burroughs Wellcome Co. Therapeutic nucleosides
US5270315A (en) * 1988-04-11 1993-12-14 Biochem Pharma Inc. 4-(purinyl bases)-substituted-1,3-dioxlanes
US5047407A (en) * 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
US5041449A (en) * 1988-04-11 1991-08-20 Iaf Biochem International, Inc. 4-(nucleoside base)-substituted-1,3-dioxolanes useful for treatment of retroviral infections
US5466806A (en) * 1989-02-08 1995-11-14 Biochem Pharma Inc. Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
NZ228645A (en) * 1988-04-11 1991-09-25 Iaf Biochem Int 1,3-dioxolane derivatives substituted in the 5th position by a purine or pyrimidine radical; treatment of viral infections
US4900828A (en) * 1988-05-12 1990-02-13 Hoffmann-Laroche Inc. Intermediate compounds and an improved procedure for the synthesis of 2',3'-dideoxycytidine
SE8802687D0 (sv) * 1988-07-20 1988-07-20 Astra Ab Nucleoside derivatives
EP0375329B1 (en) * 1988-12-19 1995-05-31 The Wellcome Foundation Limited Antiviral pyrimidine and purine compounds, process for their preparation and pharmaceutical compositions containing them
UA45942A (uk) * 1989-02-08 2002-05-15 Біокем Фарма, Інк. 1,3-оксатіолан, його похідні, спосіб (варіанти) його одержання та фармацевтична композиція
NZ233197A (en) * 1989-04-13 1991-11-26 Richard Thomas Walker Aromatically substituted nucleotide derivatives, intermediates therefor and pharmaceutical compositions
US5059690A (en) * 1990-03-01 1991-10-22 E. R. Squibb & Sons, Inc. Purinyl tetrahydrofurans
US5071983A (en) * 1989-10-06 1991-12-10 Burroughs Wellcome Co. Therapeutic nucleosides
US5350836A (en) * 1989-10-12 1994-09-27 Ohio University Growth hormone antagonists
IE904378A1 (en) * 1989-12-20 1991-07-03 Abbott Lab Analogs of oxetanyl purines and pyrimidines
US5276151A (en) * 1990-02-01 1994-01-04 Emory University Method of synthesis of 1,3-dioxolane nucleosides
US5700937A (en) * 1990-02-01 1997-12-23 Emory University Method for the synthesis, compositions and use of 2'-deoxy-5-fluoro-3'-thiacytidine and related compounds
US5204466A (en) * 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
US5527782A (en) * 1990-03-13 1996-06-18 Acic (Canada) Inc. 5-halo-2,3'-O-cyclocytidines
GB9009861D0 (en) * 1990-05-02 1990-06-27 Glaxo Group Ltd Chemical compounds
AU9125991A (en) * 1990-12-05 1992-07-08 University Of Georgia Research Foundation, Inc., The Enantiomerically pure beta -l-(-)-1,3-oxathiolane nucleosides
US5179104A (en) * 1990-12-05 1993-01-12 University Of Georgia Research Foundation, Inc. Process for the preparation of enantiomerically pure β-D-(-)-dioxolane-nucleosides
US5444063A (en) * 1990-12-05 1995-08-22 Emory University Enantiomerically pure β-D-dioxolane nucleosides with selective anti-Hepatitis B virus activity
US5248776A (en) * 1990-12-05 1993-09-28 University Of Georgia Research Foundation, Inc. Process for enantiomerically pure β-L-1,3-oxathiolane nucleosides
IL100502A (en) * 1991-01-03 1995-12-08 Iaf Biochem Int PHARMACEUTICAL PREPARATIONS CONTAINING CIS-4-AMINO-1-) 2-HYDROXIMETHIL-1,3-OXETYOLEN-5-IL (-
NZ250842A (en) * 1991-02-22 1996-03-26 Univ Emory Resolution of a racemic mixture of nucleoside enantiomers such as 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane (ftc)
GB9104740D0 (en) * 1991-03-06 1991-04-17 Wellcome Found Antiviral nucleoside combination
EP1142891B1 (en) * 1991-03-06 2007-05-02 Emory University Salts and amides of (-)cis 5-Fluoro-2'-deoxy-3'-thiacytidine useful for the treatment of hepatitis B
US5817667A (en) * 1991-04-17 1998-10-06 University Of Georgia Research Foudation Compounds and methods for the treatment of cancer
WO1992018517A1 (en) * 1991-04-17 1992-10-29 Yale University Method of treating or preventing hepatitis b virus
GB9110874D0 (en) * 1991-05-20 1991-07-10 Iaf Biochem Int Medicaments
ZA923641B (en) * 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
GB9111902D0 (en) * 1991-06-03 1991-07-24 Glaxo Group Ltd Chemical compounds
GB9116601D0 (en) * 1991-08-01 1991-09-18 Iaf Biochem Int 1,3-oxathiolane nucleoside analogues
GB9226927D0 (en) 1992-12-24 1993-02-17 Iaf Biochem Int Dideoxy nucleoside analogues
US5627160A (en) * 1993-05-25 1997-05-06 Yale University L-2',3'-dideoxy nucleoside analogs as anti-hepatitis B (HBV) and anti-HIV agents
AU1596495A (en) * 1993-12-30 1995-07-17 Genta Incorporated Improved process for the purification of oligomers
US5587362A (en) * 1994-01-28 1996-12-24 Univ. Of Ga Research Foundation L-nucleosides
IL115156A (en) * 1994-09-06 2000-07-16 Univ Georgia Pharmaceutical compositions for the treatment of cancer comprising 1-(2-hydroxymethyl-1,3-dioxolan-4-yl) cytosines
US5971983A (en) * 1997-05-09 1999-10-26 The Regents Of The University Of California Tissue ablation device and method of use

Also Published As

Publication number Publication date
KR970705393A (ko) 1997-10-09
WO1996007413A1 (en) 1996-03-14
US20050261320A1 (en) 2005-11-24
BG101284A (bg) 1998-03-31
FI970918A0 (fi) 1997-03-04
US20080171758A1 (en) 2008-07-17
DE69533066D1 (de) 2004-06-24
AU3586295A (en) 1996-03-27
SK28197A3 (en) 1997-09-10
IL115156A0 (en) 1995-12-31
BG63122B1 (bg) 2001-04-30
CZ63397A3 (en) 1997-07-16
PL318971A1 (en) 1997-07-21
KR100374477B1 (ko) 2003-06-19
JP3979662B2 (ja) 2007-09-19
ES2219666T3 (es) 2004-12-01
ATE267015T1 (de) 2004-06-15
US6063787A (en) 2000-05-16
AP783A (en) 1999-11-17
AU704977B2 (en) 1999-05-13
MY121548A (en) 2006-02-28
RU2168995C2 (ru) 2001-06-20
CZ297873B6 (cs) 2007-04-18
SI0781136T1 (en) 2004-08-31
CN1160351A (zh) 1997-09-24
PL188359B1 (pl) 2005-01-31
CN1448142A (zh) 2003-10-15
CN1251680C (zh) 2006-04-19
CN1111409C (zh) 2003-06-18
JPH10506385A (ja) 1998-06-23
PL189288B1 (pl) 2005-07-29
NO971015L (no) 1997-03-05
RO118748B1 (ro) 2003-10-30
FI970918A7 (fi) 1997-05-02
CN1827108A (zh) 2006-09-06
US8076347B2 (en) 2011-12-13
CA2199117A1 (en) 1996-03-14
BR9508886A (pt) 1997-12-30
HUT77172A (hu) 1998-03-02
SK284564B6 (sk) 2005-06-02
OA10473A (en) 2002-04-08
US7262213B2 (en) 2007-08-28
NO971015D0 (no) 1997-03-05
DE69533066T2 (de) 2005-06-02
IS4434A (is) 1997-03-04
IL115156A (en) 2000-07-16
NO313268B1 (no) 2002-09-09
EP0781136A1 (en) 1997-07-02
DK0781136T3 (da) 2004-08-02
AP9700939A0 (en) 1997-04-30
EP0781136A4 (en) 1999-06-23
EP0781136B1 (en) 2004-05-19
CA2199117C (en) 2006-04-11
NZ335013A (en) 2000-07-28
EP1468687A1 (en) 2004-10-20
PT781136E (pt) 2004-09-30
IS2011B (is) 2005-05-13
ZA957483B (en) 1997-06-06

Similar Documents

Publication Publication Date Title
FI970918L (fi) Yhdisteet ja menetelmät syövän hoitamiseksi
FI971568A7 (fi) Menetelmä resistenttien kasvainten hoitamiseksi
FI970990A7 (fi) Syövän toteaminen ja hoito
FI962954A7 (fi) Substituoidut 3-arylideeni-7-atsaoksindoliyhdisteet ja menetelmä niiden valmistamiseksi
FI972260A7 (fi) Laite ja menetelmä pintojen käsittelemiseksi
NO984431D0 (no) FremgangsmÕte for behandling av smerte
FI970762L (fi) Terapiassa käyttökelpoiset spiroatsabisykliset yhdisteet
FI960751A7 (fi) Substituoidut atsaindolylideeniyhdisteet ja menetelmä niiden valmistamiseksi
FI952996L (fi) Jätteen käsittelymenetelmä
FI972484L (fi) Karsinooman hoito
FI970534L (fi) Menetelmät ja koostumukset endotoksiinin liittyvien tilojen ennaltaehkäisemiseksi ja hoitamiseksi
FI965008L (fi) Koostumukset ja menetelmät kasvainten hoitamiseksi
ID17723A (id) Senyawa untuk pengobatan
FI951060L (fi) Formulaatioita ja hoitomenetelmiä
FI960658L (fi) Uudet bis-naftalimidit syövän hoitamiseksi
IS4789A (is) Meðferðarefnasambönd
NO984446D0 (no) FremgangsmÕte for behandling av smerte
NO982582D0 (no) FremgangsmÕte for behandling av smerte
AU5369498A (en) Compounds and methods for treating cancer
BR9510494A (pt) Conjunto de elementos de irradiação
ID16924A (id) Metode perlakuan poliolefin
FI970098A7 (fi) Menetelmä ja yhdiste hiustenlähdön hoitamiseksi
FI964783L (fi) Menetelmä syövän hoitamiseksi p53-proteiinia säätelemällä
EE200000074A (et) Meetod ja seade jäätmete töötlemiseks
KR970702940A (ko) 스트립 처리장치(strip treating apparatus)